Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kevin Carroll

Showing results (1-10 of 52) with videos related to

Pageof 6
Sort By:
Physical Medicine and Rehabilitation Clinics of North America|March 7, 2006
Lower extremity socket design and suspensionKevin Carroll
Physician Executive|September 29, 2009
8 insights for physicians joining the life science industryKevin Carroll
Tropical Doctor|February 13, 2004
Comparison of outcomes from a district tuberculosis control programme in the Pacific: before and after the implementation of DOTSKevin Carroll, George Malefoasi
Pharmaceutical Statistics|January 7, 2016
On the need for increased rigour and care in the conduct and interpretation of network meta-analyses in drug developmentKevin Carroll, Robert Hemmings
Pharmaceutical Statistics|April 23, 2008
Literature review: January-March 2008Scott D Patterson, Kevin Carroll
Statistics in Medicine|August 19, 2004
Design and analysis of non-inferiority mortality trials in oncologyKevin Carroll, Bob Milsted, John A Lewis
Pharmaceutical Statistics|May 22, 2018
Investigation of mixed model repeated measures analyses and non-linear random coefficient models in the context of long-term efficacy dataBruno Delafont, Kevin Carroll, Claire Vilain, et al.
Journal of Public Health Medicine|April 3, 2003
Prevalence and management of coronary heart disease in primary care: population-based cross-sectional study using a disease registerKevin Carroll, Azeem Majeed, Caroline Firth, et al.
Statistical Methods in Medical Research|February 21, 2008
Individual- and trial-level surrogacy in colorectal cancerMarc Buyse, Tomasz Burzykowski, Stefan Michiels, et al.
Cost Effectiveness and Resource Allocation : C/E|February 18, 2020
Evaluation of the cost-effectiveness of dexrazoxane for the prevention of anthracycline-related cardiotoxicity in children with sarcoma and haematologic malignancies: a European perspectiveSarah Dewilde, Kevin Carroll, Emilia Nivelle, et al.
Pageof 6

Showing results (1-10 of 52) with videos related to

Sort By:
Pageof 6
Physical Medicine and Rehabilitation Clinics of North America|March 7, 2006
Lower extremity socket design and suspensionKevin Carroll
Physician Executive|September 29, 2009
8 insights for physicians joining the life science industryKevin Carroll
Tropical Doctor|February 13, 2004
Comparison of outcomes from a district tuberculosis control programme in the Pacific: before and after the implementation of DOTSKevin Carroll, George Malefoasi
Pharmaceutical Statistics|January 7, 2016
On the need for increased rigour and care in the conduct and interpretation of network meta-analyses in drug developmentKevin Carroll, Robert Hemmings
Pharmaceutical Statistics|April 23, 2008
Literature review: January-March 2008Scott D Patterson, Kevin Carroll
Statistics in Medicine|August 19, 2004
Design and analysis of non-inferiority mortality trials in oncologyKevin Carroll, Bob Milsted, John A Lewis
Pharmaceutical Statistics|May 22, 2018
Investigation of mixed model repeated measures analyses and non-linear random coefficient models in the context of long-term efficacy dataBruno Delafont, Kevin Carroll, Claire Vilain, et al.
Journal of Public Health Medicine|April 3, 2003
Prevalence and management of coronary heart disease in primary care: population-based cross-sectional study using a disease registerKevin Carroll, Azeem Majeed, Caroline Firth, et al.
Statistical Methods in Medical Research|February 21, 2008
Individual- and trial-level surrogacy in colorectal cancerMarc Buyse, Tomasz Burzykowski, Stefan Michiels, et al.
Cost Effectiveness and Resource Allocation : C/E|February 18, 2020
Evaluation of the cost-effectiveness of dexrazoxane for the prevention of anthracycline-related cardiotoxicity in children with sarcoma and haematologic malignancies: a European perspectiveSarah Dewilde, Kevin Carroll, Emilia Nivelle, et al.
Pageof 6